Pomegranate Review

Name: Pomegranate Review
Item: Pomegranate
Rating: 3.5
Author: GLP-1 Scout

Pomegranate positions itself as a fully online weight-loss provider that routes approved prescriptions to partner pharmacies. The current public marketing bar is much cleaner than the older local draft: transparent pricing, no membership requirement language, and a visible online workflow backed by live onboarding prices.

The trade-off is that the fine print is still real. Subscription terms describe auto-renewal, nonrefundable membership or consultation fees when charged, nonreturnable medication fees, and pharmacy assignment based on availability rather than shopper preference.

Pomegranate now shows live starter pricing through its onboarding flow: semaglutide starts at $119 per month and tirzepatide starts at $179 per month, while the public site still markets no membership requirements and 3-5 business day turnaround times.

3.5 /5

Trustpilot

3.5 /5

Review count

109

Semaglutide start

$119/mo

Visit Pomegranate pricing

About Pomegranate

Pomegranate is strongest for shoppers who want live onboarding prices and a fully online GLP-1 workflow before committing to intake. It is weaker if you want brand-only treatment, guaranteed pharmacy choice, or very simple cancellation rules.

Why it's for you

The current onboarding flow publishes starter pricing instead of hiding it behind a sales call: semaglutide starts at $119 per month and tirzepatide starts at $179 per month.
The public site markets a 100% online process, transparent pricing, no membership requirements, and a typical 3-5 business day turnaround after approval.
Pomegranate says approved prescriptions are sent to partner pharmacies, and the live pricing flow shows multiple pharmacy options instead of a single unnamed fulfillment path.
The onboarding flow also spells out an eligibility nuance many sites skip: current GLP-1 users with lower BMI may still be reviewed for maintenance dosing if eligible.

Why it's not for you

Compounded GLP-1 products in the onboarding flow are not evaluated or approved by the FDA for quality, safety, or efficacy.
Subscription terms say plans can renew automatically until canceled, and that membership plus one-time consultation fees are nonrefundable when charged.
Medication fees are described as nonrefundable and nonreturnable, so the cancellation window is tighter than the homepage marketing bar suggests.
Pharmacy choice is not guaranteed, requesting a specific pharmacy can trigger a $150 coordination fee, and the current semaglutide path flags CA, IA, and WI as unavailable for one listed option.

Eligibility for Pomegranate

Pomegranate does not promise approval to everyone. The current onboarding flow says new GLP-1 patients generally need a BMI of 27 or higher with a comorbidity, or 30 or higher without one, while current GLP-1 users with lower BMI may still be reviewed for maintenance dosing if eligible.

Likely a better fit if

You want to see live cash-pay starter pricing before committing to a GLP-1 intake.
You are comfortable with a telehealth workflow where a provider reviews your history, may request recent labs or records, and sends approved prescriptions to a partner pharmacy.
You are open to compounded semaglutide or tirzepatide pathways and can work within the stated eligibility thresholds.

May be a weaker fit if

You only want FDA-approved brand-name pens and do not want compounded medication in the conversation.
You need every state and pharmacy path to look identical; the current pricing flow still shows pharmacy-specific availability limits.
You want very flexible post-purchase refunds or a long cancellation window after the consultation is booked.

Program tiers

Use these tiers to understand how this program separates plan levels, medication paths, or support inclusions.

Tier	What's included
Compounded semaglutide starter path	$119 per month to start on the current onboarding flow, with 1-, 2-, 4-, and 6-month options shown through pharmacies such as Empower, Hallandale, Redrock, and OptioRx.
Compounded tirzepatide starter path	$179 per month to start, with 1-, 3-, and 6-month options shown and partner-pharmacy choices including BPI.
Maintenance or continuing-patient review	Patients already on a GLP-1 with BMI below 27 may still be evaluated for maintenance dosing if eligible, so the platform is not limited to brand-new starts.
Availability and pharmacy caveats	The current semaglutide flow flags CA, IA, and WI as unavailable for one option, and one listed pharmacy is limited to two vials per order because of USP 797 and beyond-use-date restrictions.

Program choices and options

Pomegranate's real choices are clearer in the live onboarding flow than on the broad marketing pages. The practical decision is which compounded ingredient path you want, how much supply you want at one time, and whether the pharmacy restrictions on your selected option still work for your state.

That also means the checkout screen matters more than the homepage headline. The public site emphasizes simple access, but the subscription and pharmacy details only become obvious when you compare the actual pricing tracks and terms together.

1. Semaglutide + B12 for the lowest visible starter price

The semaglutide path is the easiest place to start if budget is the main filter. Pomegranate currently shows it at $119 per month to start, which is materially lower than the older draft preserved in this repo.

The trade-off is that this path also carries the clearest state and pharmacy caveats, so shoppers should verify availability before treating the headline number as universally accessible.

$119 per month starter pricing on the captured onboarding flow.
1-, 2-, 4-, and 6-month option lengths are visible.
Current capture flags CA, IA, and WI as unavailable for one semaglutide option.

2. Tirzepatide + B6 for a higher-cost step-up

The tirzepatide path starts higher at $179 per month, but it stays visible and shoppable without forcing a blind intake first. That makes it easier to compare against other telehealth offers that bury tirzepatide pricing until later in the funnel.

This is the more relevant track for shoppers who already expect to discuss tirzepatide specifically and want to compare supply durations before they start.

$179 per month starter pricing on the captured onboarding flow.
1-, 3-, and 6-month option lengths are visible.
Partner-pharmacy choices include BPI alongside other listed options.

3. Maintenance dosing review for current GLP-1 users

Pomegranate does not frame every user as a new starter. The onboarding flow says patients already on a GLP-1 with BMI below 27 may still be reviewed for maintenance dosing if they qualify.

That matters because it broadens the use case beyond first-time weight-loss shoppers and gives existing GLP-1 users a more realistic reason to compare the platform.

Maintenance review is explicitly mentioned on the captured onboarding page.
Provider approval is still required; it is not an automatic refill promise.

4. Subscription rules and pharmacy assignment

The most important operational choice is whether you are comfortable with Pomegranate's post-checkout rules. The subscription terms say plans can renew automatically until canceled, and that deleting the app does not itself cancel a subscription.

They also say pharmacy assignment depends on availability and clinical judgment. If you want to request a specific pharmacy, the terms describe a $150 coordination fee and still stop short of guaranteeing that pharmacy can fill the order.

Automatic renewal continues until you cancel the selected plan.
Membership and one-time consultation fees are nonrefundable when charged.
Medication fees are nonrefundable and nonreturnable.

Detailed review

Live onboarding pricing is now the strongest source

The older local Pomegranate draft leaned on promo math and a one-time consult fee. The current live onboarding flow is more useful because it surfaces ingredient-specific starter pricing directly: semaglutide starts at $119 per month and tirzepatide starts at $179 per month, with visible supply-length options tied to named partner pharmacies.

That shift makes Pomegranate easier to compare against Eden, OrderlyMeds, and Fifty 410 on day one. The homepage still markets transparent pricing and no membership requirements, but the onboarding flow is where the actual GLP-1 decision-making happens.

Eligibility, labs, and provider review

Pomegranate's public pages are clearer than before about who may qualify. The homepage says GLP-1 eligibility depends on medical history, BMI, and physician assessment, while the onboarding flow adds a more specific rule: patients new to a GLP generally need a BMI of 27 or higher with a comorbidity, or 30 or higher without one.

The weight-loss page also says recent labs or medical records may be requested in some cases, not automatically for everyone. If approved, prescriptions are routed to a partner pharmacy, which is the safest way to describe the telehealth workflow without overstating what happens before clinician review.

Pharmacies, timing, and state caveats

Pomegranate describes itself as a fully online service with partner-pharmacy fulfillment. Across the homepage and weight-loss page, the captured promise is a typical 3-5 business day turnaround after consultation and approval, with the final timing still dependent on pharmacy processing and shipping.

The live pricing flow is also honest enough to show operational caveats. One semaglutide option is flagged as unavailable in California, Iowa, and Wisconsin, and one listed pharmacy is limited to two vials per order because of USP 797 and beyond-use-date restrictions. Those details are useful precisely because they interrupt the illusion that every telehealth GLP-1 track works the same way in every state.

Renewal, refund, and arbitration fine print

The biggest caution with Pomegranate is not the front-end pricing; it is the terms. The subscription page says trials can convert automatically unless you cancel at least 24 hours before they end, and that selected plans renew automatically until canceled. It also states that membership and one-time consultation fees are nonrefundable when charged, while medication fees are nonrefundable and nonreturnable.

Pharmacy selection is also narrower than some shoppers may expect. The terms say sourcing depends on availability and clinical judgment, and that requesting a specific pharmacy can add a $150 coordination fee without guaranteeing fulfillment. Pomegranate's Terms of Service separately include binding individual arbitration unless the user opts out through the described dispute process.

Compounded medication caveat

Pomegranate's onboarding flow is explicit that compounded medications are prepared by state-licensed pharmacies in compliance with applicable regulations and have not been evaluated or approved by the FDA for quality, safety, or efficacy. That means this review should be read first as a cash-pay compounded-GLP-1 telehealth assessment, not as a guarantee of brand-name FDA-approved treatment.

Bottom line

Pomegranate is a better fit for shoppers who want to see real starter pricing before intake, are comfortable with partner-pharmacy fulfillment, and can evaluate a telehealth GLP-1 offer with the terms open beside the checkout page. It is a weaker fit for people who want guaranteed pharmacy choice, brand-only treatment, or flexible refunds after payment.

Expert take

Keith Murphy

Senior Editor

Pomegranate is attractive if you want low starter prices on compounded GLP-1s, clear promotional tiers, and shipping that often puts multiple months in one box. The value is strongest when you read the promo page closely, line up your labs, and plan around pharmacy processing.

It is not the best fit if you need brand-only pens, flexible returns after prescription processing, or if you dislike arbitration terms. If you proceed, budget from the exact page you buy from, save the PDF subscription terms, and turn on carrier tracking so refills stay predictable.